Nyxoah (BR:NYXH) — Market Cap & Net Worth
Market Cap & Net Worth: Nyxoah (NYXH)
Nyxoah (BR:NYXH) has a market capitalization of $70.73 Million (€60.50 Million) as of June 16, 2026. Listed on the BR stock exchange, this Belgium-based company holds position #20633 globally and #90 in its home market, demonstrating a -42.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nyxoah's stock price €1.41 by its total outstanding shares 43026460 (43.03 Million). Review how much debt does Nyxoah carry to assess the company's total debt and financial obligations.
Nyxoah Market Cap History: 2020 to 2026
Nyxoah's market capitalization history from 2020 to 2026. Data shows change from $794.78 Million to $70.73 Million (-36.78% CAGR).
Index Memberships
Nyxoah is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
BEL Small
BELS
|
$5.84 Billion | 1.21% | #19 of 20 |
|
BEL All Share
BSPT
|
$854.19 Billion | 0.01% | #92 of 108 |
Weight: Nyxoah's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nyxoah Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nyxoah's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
91.90x
Nyxoah's market cap is 91.90 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $794.78 Million | $69.00K | -$12.24 Million | 11518.53x | N/A |
| 2021 | $935.63 Million | $852.00K | -$27.62 Million | 1098.15x | N/A |
| 2022 | $258.55 Million | $3.08 Million | -$31.23 Million | 83.84x | N/A |
| 2023 | $214.29 Million | $4.35 Million | -$43.21 Million | 49.28x | N/A |
| 2024 | $415.50 Million | $4.52 Million | -$59.24 Million | 91.90x | N/A |
Competitor Companies of NYXH by Market Capitalization
Companies near Nyxoah in the global market cap rankings as of June 16, 2026.
Key companies related to Nyxoah by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #162 globally with a market cap of $145.58 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $98.90 Billion USD ( €84.60 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #344 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #537 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Intuitive Surgical Inc | NASDAQ:ISRG | $145.58 Billion | $411.06 |
| #258 | EssilorLuxottica S. A. | PA:EL | $98.90 Billion | €182.70 |
| #344 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €90.00 |
| #537 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Nyxoah Historical Marketcap From 2020 to 2026
Between 2020 and today, Nyxoah's market cap moved from $794.78 Million to $ 70.73 Million, with a yearly change of -36.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €70.73 Million | -65.58% |
| 2025 | €205.49 Million | -50.54% |
| 2024 | €415.50 Million | +93.90% |
| 2023 | €214.29 Million | -17.12% |
| 2022 | €258.55 Million | -72.37% |
| 2021 | €935.63 Million | +17.72% |
| 2020 | €794.78 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 15th, 2026 the market cap of Nyxoah was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $70.73 Million USD |
| MoneyControl | $70.73 Million USD |
| MarketWatch | $70.73 Million USD |
| marketcap.company | $70.73 Million USD |
| Reuters | $70.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nyxoah
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgi… Read more